Domestic pharmaceutical companies have poured out 42 generics of Baraclude just in this year

Domestic pharmaceutical companies have shown interests in type B hepatitis treatments.

According to the Ministry of Food and Drug Safety, generics of ‘Baraclude (entecavir),’ which were first introduced by BMS Korea in Korea in 2006, are poured out since the last year.

While 50 products were approved in 2014, 42 products were additionally launched by this 14^th in 2015, making 92 products in t...